Inventor · disambiguated record
Xiaoning Shen
Also filed as: SHEN XIAONING
5 granted patents·3 pending applications·3 citations·filing 2017–2022
64Inventor score
Files withSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD6INNOVENT BIOLOGICS SUZHOU CO LTD1ZHEJIANG TERUISI PHARMACEUTICAL INC1
Top patents by PatentIndex Score
8 records- 0183US11274153B2Anti-PD-L1 nanobody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2017·Granted Mar 15, 2022·3 cites·11 claims
- 0254US11427635B2CD47 single-domain antibody and use thereofSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD·Filed 2018·Granted Aug 30, 2022·0 cites·16 claims
- 0352US12012456B2Anti-interleukin-4 receptor (IL-4R) single-domain antibody, encoding polynucleotide and methods of making and using the antibody for IL-4R detection and disease treatmentSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD·Filed 2020·Granted Jun 18, 2024·0 cites·21 claims
- 0449US2024368264A1Anti-TSLP nanobodies and their applicationsSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0547US11912770B2Blocking type PD-L1 single-domain camel antibody and application thereofSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD·Filed 2019·Granted Feb 27, 2024·0 cites·15 claims
- 0647US2023399395A1Anti-il5 nanoantibody and use thereofSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0742US11292841B2Anti-PD-1 nano-antibody and application thereofZHEJIANG TERUISI PHARMACEUTICAL INC·Filed 2017·Granted Apr 5, 2022·0 cites·11 claims
- 0839US2022324954A1Anti-vegf single-domain antibody and use thereofSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaoning Shen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →